Literature DB >> 16227354

Following the TRAIL from hepatitis C virus and alcohol to fatty liver.

S C Afford1, D H Adams.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16227354      PMCID： PMC1774725          DOI： 10.1136/gut.2005.067801

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  28 in total

Review 1.  Cytokines in alcoholic and nonalcoholic steatohepatitis.

Authors:  H Tilg; A M Diehl
Journal:  N Engl J Med       Date:  2000-11-16       Impact factor: 91.245

2.  Tumor necrosis factor alpha in the pathogenesis of human and murine fulminant hepatic failure.

Authors:  K Streetz; L Leifeld; D Grundmann; J Ramakers; K Eckert; U Spengler; D Brenner; M Manns; C Trautwein
Journal:  Gastroenterology       Date:  2000-08       Impact factor: 22.682

Review 3.  Signalling pathways of the TNF superfamily: a double-edged sword.

Authors:  Bharat B Aggarwal
Journal:  Nat Rev Immunol       Date:  2003-09       Impact factor: 53.106

4.  Involvement of TRAIL and its receptors in viral hepatitis.

Authors:  Bettina Mundt; Florian Kühnel; Lars Zender; Yasmin Paul; Hans Tillmann; Christian Trautwein; Michael Peter Manns; Stefan Kubicka
Journal:  FASEB J       Date:  2002-11-15       Impact factor: 5.191

Review 5.  TRAIL-induced signalling and apoptosis.

Authors:  Marion MacFarlane
Journal:  Toxicol Lett       Date:  2003-04-04       Impact factor: 4.372

6.  Human normal hepatocytes are susceptible to apoptosis signal mediated by both TRAIL-R1 and TRAIL-R2.

Authors:  E Mori; M Thomas; K Motoki; K Nakazawa; T Tahara; K Tomizuka; I Ishida; S Kataoka
Journal:  Cell Death Differ       Date:  2004-02       Impact factor: 15.828

7.  Hepatitis B virus enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) cytotoxicity by increasing TRAIL-R1/death receptor 4 expression.

Authors:  Harry L A Janssen; Hajime Higuchi; Ahmad Abdulkarim; Gregory J Gores
Journal:  J Hepatol       Date:  2003-09       Impact factor: 25.083

8.  Critical roles of TRAIL in hepatic cell death and hepatic inflammation.

Authors:  Shi-Jun Zheng; Pu Wang; Galit Tsabary; Youhai H Chen
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

9.  Activated stellate cells express the TRAIL receptor-2/death receptor-5 and undergo TRAIL-mediated apoptosis.

Authors:  Pavel Taimr; Hajime Higuchi; Eva Kocova; Richard A Rippe; Scott Friedman; Gregory J Gores
Journal:  Hepatology       Date:  2003-01       Impact factor: 17.425

Review 10.  Modulation of life and death by the TNF receptor superfamily.

Authors:  S J Baker; E P Reddy
Journal:  Oncogene       Date:  1998-12-24       Impact factor: 9.867
View more
  4 in total

1.  Primary and malignant cholangiocytes undergo CD40 mediated Fas dependent apoptosis, but are insensitive to direct activation with exogenous Fas ligand.

Authors:  Elizabeth H Humphreys; Kevin T Williams; David H Adams; Simon C Afford
Journal:  PLoS One       Date:  2010-11-17       Impact factor: 3.240

2.  sTRAIL levels and TRAIL gene polymorphisms in Chinese patients with fatty liver disease.

Authors:  Xiaohua Yan; Liyun Xu; Jianni Qi; Xiaohong Liang; Chunhong Ma; Chun Guo; Lining Zhang; Wensheng Sun; Jiyun Zhang; Xiaoyi Wei; Lifen Gao
Journal:  Immunogenetics       Date:  2009-07-23       Impact factor: 2.846

3.  TRAIL mediates liver injury by the innate immune system in the bile duct-ligated mouse.

Authors:  Alisan Kahraman; Fernando J Barreyro; Steven F Bronk; Nathan W Werneburg; Justin L Mott; Yuko Akazawa; Howard C Masuoka; Charles L Howe; Gregory J Gores
Journal:  Hepatology       Date:  2008-04       Impact factor: 17.425

4.  Characterization of HCV interactions with Toll-like receptors and RIG-I in liver cells.

Authors:  Erika A Eksioglu; Haizhen Zhu; Lilly Bayouth; Jennifer Bess; Hong-Yan Liu; David R Nelson; Chen Liu
Journal:  PLoS One       Date:  2011-06-17       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.